News

Roche recognised as leader in sustainability by Dow Jones Sustainability Indices

EIT Health Core Partner Roche ranked the most sustainable healthcare company in the Dow Jones Sustainability Indices.

As a global pioneer in pharmaceuticals and diagnostics, Roche is focused on finding better ways to prevent, diagnose and treat diseases and make a sustainable contribution to society. Beyond improving access to products, the company’s sustainability efforts are also visible in the area of social responsibility, environmental protection, supply chain sustainability, people attraction and retention. Fully embedded in the company’s business strategy and culture, these efforts have been continuously recognized and this year is no exemption.

On 16 November 2020, the Pharmaceutical index of the Dow Jones Sustainability Indices (DJSI) ranked Roche the most sustainable company – for the eleventh time. Roche’s performed particularly well in Marketing Practices, Environmental and Social Reporting, Operational Eco-Efficiency, Climate Strategy, and Corporate Citizenship and Philanthropy.

The DJSI is a global ranking, which is published annually by S&P Dow Jones Indices and SAM, as an indication of the performance of global sustainability leaders. The ranking is based on an in-depth evaluation of the corporate economic, social and environmental performance as well as on industry-specific sustainability trends, thus regarded as a benchmark for investors who integrate sustainability considerations into their portfolios. Companies are selected for the indices according to a systematic Corporate Sustainability Assessment (CSA) performed by SAM.

Roche is aware that keeping their sustainability leadership position requires constant work and collaboration. Partnering with stakeholders and engaging in open dialogues is essential for sustainable value creation and growth – now more than ever.

We are proud of being recognised once again for our sustainability efforts. At Roche, we know that the key to creating sustainable value and growth lies in partnering with multiple stakeholders. The COVID-19 pandemic has exacerbated the need for public and private sectors across the globe to work together to address this challenge. In these unprecedented times, we are more than ever committed to work in close collaboration with all global health actors to ensure that medicines and diagnostics reach the people who need them”, says Severin Schwan, CEO at Roche.

Examples of Roche activities in sustainability areas can be found here.